MCVEY (Medicover AB) Piotroski F-Score: 6 (As of Aug. 04, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MCVEY Medicover AB MCVEY
92 GF Score
Price $16.55
GF Value $17.30
! 5 Warning Signs
View Full Analysis

What is Medicover AB Piotroski F-Score?

Medicover AB MCVEY 92 Piotroski F-Score is 6 as of Aug. 04, 2026, which is at its 10-year median of 6.00. GuruFocus rates MCVEY with a GF Score™ of 92/100 and a GF Value™ of $17.30. The stock has 5 warning signs investors should review. Among 645 Healthcare Providers & Services companies, Medicover AB ranks better than 75.35% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medicover AB has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Medicover AB's Piotroski F-Score or its related term are showing as below:

MCVEY' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 6

During the past 12 years, the highest Piotroski F-Score of Medicover AB was 8. The lowest was 3. And the median was 6.

Medicover AB  (OTCPK:MCVEY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Medicover AB Piotroski F-Score Related Terms


Medicover AB Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Medicover AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Piotroski F-Score Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 4.00 6.00 6.00 6.00

Medicover AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 6.00 7.00 6.00

MCVEY vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Medicover AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Medicover AB's Piotroski F-Score falls into.


MCVEY
92GF Score
Medicover AB MCVEY
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 22.887 + 22.014 + 25.549 + 28.226 = $99 Mil.
Cash Flow from Operations was 115.962 + 117.213 + 84.046 + 84.793 = $402 Mil.
Revenue was 694.366 + 716.276 + 721.618 + 737.788 = $2,870 Mil.
Gross Profit was 162.911 + 160.539 + 170.173 + 177.074 = $671 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(2674.51 + 2745.54 + 2834.778 + 2803.121 + 2806.221) / 5 = $2772.834 Mil.
Total Assets at the begining of this year (Jun25) was $2,675 Mil.
Long-Term Debt & Capital Lease Obligation was $994 Mil.
Total Current Assets was $610 Mil.
Total Current Liabilities was $1,110 Mil.
Net Income was -4.883 + 9.005 + 21.73 + 22.03 = $48 Mil.

Revenue was 585.794 + 581.99 + 624.973 + 688.235 = $2,481 Mil.
Gross Profit was 125.527 + 126.387 + 143.459 + 163.899 = $559 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(2193.326 + 2281.021 + 2238.953 + 2352.216 + 2674.51) / 5 = $2348.0052 Mil.
Total Assets at the begining of last year (Jun24) was $2,193 Mil.
Long-Term Debt & Capital Lease Obligation was $1,369 Mil.
Total Current Assets was $550 Mil.
Total Current Liabilities was $630 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medicover AB's current Net Income (TTM) was 99. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medicover AB's current Cash Flow from Operations (TTM) was 402. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=98.676/2674.51
=0.03689498

ROA (Last Year)=Net Income/Total Assets (Jun24)
=47.882/2193.326
=0.02183077

Medicover AB's return on assets of this year was 0.03689498. Medicover AB's return on assets of last year was 0.02183077. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Medicover AB's current Net Income (TTM) was 99. Medicover AB's current Cash Flow from Operations (TTM) was 402. ==> 402 > 99 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=993.548/2772.834
=0.35831499

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=1368.743/2348.0052
=0.58293866

Medicover AB's gearing of this year was 0.35831499. Medicover AB's gearing of last year was 0.58293866. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=610.484/1110.023
=0.54997419

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=550.404/629.642
=0.87415388

Medicover AB's current ratio of this year was 0.54997419. Medicover AB's current ratio of last year was 0.87415388. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Medicover AB's number of shares in issue this year was 151.974. Medicover AB's number of shares in issue last year was 150.979. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=670.697/2870.048
=0.23368843

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=559.272/2480.992
=0.22542273

Medicover AB's gross margin of this year was 0.23368843. Medicover AB's gross margin of last year was 0.22542273. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=2870.048/2674.51
=1.07311171

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=2480.992/2193.326
=1.13115515

Medicover AB's asset turnover of this year was 1.07311171. Medicover AB's asset turnover of last year was 1.13115515. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+0+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medicover AB has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Medicover AB (MCVEY) has a Piotroski F-Score of 6 as of Aug. 04, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medicover AB and its competitors. This is near median its historical median of 6.00. Over the past decade, Medicover AB's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Medicover AB ranks #159 out of 645 companies in the Healthcare Providers & Services industry, placing it in the top 24.7%.
Is Medicover AB's Piotroski F-Score too high?
Medicover AB's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Medicover AB's value of 6 is 20% above this industry median. Based on the distribution chart, Medicover AB ranks #159 out of 645 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medicover AB has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #159 out of 645 companies for Piotroski F-Score. This places Medicover AB in the top 25% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Medicover AB's value of 6 is 20% above this benchmark. Historically, Medicover AB's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Medicover AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicover AB's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Medicover AB (MCVEY) has a current Piotroski F-Score of 6. The stock's GF Value™ is $17.30, compared to a current price of $16.55 — trading 4.3% below its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Healthcare Providers & Services industry median of 5.00. Medicover AB's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Medicover AB (MCVEY), the current Piotroski F-Score is 6 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (MCVEY) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued. The current stock price of $16.55 is trading 4.3% below its estimated GF Value™ of $17.30.

Key valuation signals for MCVEY:

  • Piotroski F-Score: 6 (near median its 10-year median of 6.00)
  • GF Value™: $17.30 vs. price of $16.55 (4.3% below fair value)
  • GF Score™: 92/100 with 5 warning signs
  • Industry Position: 20% above the Healthcare Providers & Services median (#159 of 645)

No single metric tells the full story. See the MCVEY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
92GF Score

Get the complete analysis for MCVEY

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.55
Price
$17.30
GF Value